Lv11
80 积分 2022-10-21 加入
A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer
25天前
已完结
Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
25天前
已完结
Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial
1个月前
已完结
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer
1个月前
已完结
A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way
1个月前
已完结
Immunotherapy in Stage III–IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database
2个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
3个月前
已完结
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
4个月前
已完结
Colorectal cancer
6个月前
已完结
Research advances in traditional Chinese medicine syndromes in cancer patients
6个月前
已完结
皖公网安备34019202002308
